V

VIB

1462 employees

VIB, a Belgium-based life sciences research institute, performs research for pharmaceutical, agricultural, and industrial applications.

Investor insights

Sectors invested in

Biotechnology14
Agriculture6
Health Care5
Chemical4
Food Protection and Crop Protection3
biostimulants3
biologicals3
Research and development3
Microbiology3
biocontrol3
AgTech3
Pharmaceutical3
Health Diagnostics2
Medical2
Biopharma2
Therapeutics1
Life Science1
Industrial1
intestine1
Microbiome1

Funding rounds participated in

$8M sweet spot round size

Most of their 20 investments are in rounds between $4.7M and $17M

Investor type

Venture Capital

Basic info

Industry

research services

Sectors

Biotechnology
Science Communication
Microbiology
Structural Biology
Computational Biology
Life Sciences
Plant Biology
Medical Biotechnology
Neuroscience
Translational Research
Cancer Research
Venture Capital
Immunity & Inflammation

Date founded

1995

Investments made

d

dualyx raised $44M on May 15, 2023

Investors: KU Leuven Innovation & Entrepreneurship, V-Bio Ventures, Andera Partners, Forbion, High-Tech Gründerfonds, BGV (BioGeneration Ventures) and VIB

M

Muna Therapeutics raised $73M on July 9, 2021

Investors: Sanofi Ventures, Sofinnova Partners, Novo Holdings, LSP (Life Sciences Partners), Polaris Partners, V-Bio Ventures and VIB

A

Aphea.Bio raised $22M on April 14, 2021

Investors: KU Leuven Innovation & Entrepreneurship, Vives Louvain Technology Fund, V-Bio Ventures, European Circular Bioeconomy Fund and VIB

A

Aphea.Bio raised $4.7M on April 1, 2021

Investors: KU Leuven Innovation & Entrepreneurship, Vives Louvain Technology Fund, European Circular Bioeconomy Fund, Qbic and VIB

A

Animab raised $4M on October 27, 2020

Investors: V-Bio Ventures, Seventure Partners and VIB

E

ExeVir raised $49M on July 28, 2020

Investors: SRIW, Vives Louvain Technology Fund, -, FundPlus, UCB Ventures, V-Bio Ventures and VIB

U

Undisclosed raised $9.1M on February 20, 2020

Investors: ALSA Ventures, Polaris Partners, KU Leuven and VIB

M

MRM Health raised $15M on February 19, 2020

Investors: Qbic, Danisco India Pvt. Ltd., Ackermans & van Haaren and VIB

A

Augustine Therapeutics raised $4.7M on December 16, 2019

Investors: KU Leuven Innovation & Entrepreneurship, AdBio partners, V-Bio Ventures and VIB

B

Biotalys NV raised $39M on July 30, 2019

Investors: Gimv, Qbic, Sofinnova Partners, Ackermans & van Haaren and VIB

FAQ